Back
Intra-Cellular Therapies Vs. Merck & Industry Stock Comparison
Sell
19
ITCI
Intra-Cellular Therapies
Last Price:
73.53
Seasonality Move:
7.83%
Sell
50
MRK
Merck &
Last Price:
117.82
Seasonality Move:
3.94%
Sell
19
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $73.52. The Score for ITCI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
50
Merck & (MRK)
is a Sell
Is Merck & a Buy, Sell or Hold?
- The current Merck & [MRK] share price is $117.84. The Score for MRK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- MRK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $73.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
MRK Stock Price Chart
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.75 | Sell |
| Relative Strength Index (14 RSI): | 46.1 | Sell |
| Chaikin Money Flow: | -514822 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.04 - 76.28) | Sell |
| Bollinger Bands (100): | (68.13 - 76.69) | Buy |
MRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 51.47 | Buy |
| Chaikin Money Flow: | -7270827 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.32 - 117.22) | Buy |
| Bollinger Bands (100): | (118.3 - 130.94) | Sell |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.98 | Buy |
| 20-day SMA: | 74.25 | Sell |
| 50-day SMA: | 75.03 | Sell |
| 200-day SMA: | 69.81 | Buy |
| 8-day EMA: | 73.25 | Buy |
| 20-day EMA: | 74.11 | Sell |
| 50-day EMA: | 74.13 | Sell |
| 200-day EMA: | 69.38 | Buy |
MRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 117.33 | Buy |
| 20-day SMA: | 115.83 | Buy |
| 50-day SMA: | 120.11 | Sell |
| 200-day SMA: | 121.6 | Sell |
| 8-day EMA: | 117.22 | Buy |
| 20-day EMA: | 116.95 | Buy |
| 50-day EMA: | 119.48 | Sell |
| 200-day EMA: | 120.28 | Sell |
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
Merck & Earnings Growth & MRK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.62 per share, an increase this year of $6.81 per share, and an increase next year of $1.56 per share.
Intra-Cellular Therapies Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merck & Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||